Board member Mick Hitchcock, named interim CEO replacing Thomas Butler.COO and President Ramses Erdtmann continuing at Biomea in current ...
Healthcare Analysts provide expert insights on current and emerging treatments for Systemic Mastocytosis (relevant companies Blueprint ...
The startup is bringing into Phase 1 testing an experimental treatment it says could be more effective than marketed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback